FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 206 filers reported holding FATE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,197,273 | -55.8% | 2,451,544 | -0.7% | 0.01% | -51.7% |
| Q2 2023 | $11,753,863 | +24.0% | 2,469,299 | +48.5% | 0.03% | +20.8% |
| Q1 2023 | $9,475,230 | +63.2% | 1,662,321 | +188.8% | 0.02% | +50.0% |
| Q4 2022 | $5,806,956 | +107.2% | 575,516 | +360.4% | 0.02% | +100.0% |
| Q3 2022 | $2,802,000 | -17.7% | 125,003 | -9.0% | 0.01% | -11.1% |
| Q2 2022 | $3,406,000 | -29.7% | 137,419 | +9.9% | 0.01% | -18.2% |
| Q1 2022 | $4,846,000 | -33.7% | 125,000 | 0.0% | 0.01% | -21.4% |
| Q4 2021 | $7,314,000 | -1.3% | 125,000 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $7,409,000 | -31.7% | 125,000 | 0.0% | 0.01% | -30.0% |
| Q2 2021 | $10,849,000 | -34.1% | 125,000 | -37.4% | 0.02% | -37.5% |
| Q1 2021 | $16,472,000 | -28.3% | 199,785 | -20.9% | 0.03% | -31.9% |
| Q4 2020 | $22,969,000 | +111.9% | 252,601 | -6.9% | 0.05% | +88.0% |
| Q3 2020 | $10,842,000 | -13.7% | 271,258 | -25.9% | 0.02% | -19.4% |
| Q2 2020 | $12,559,000 | +21.7% | 366,052 | -21.2% | 0.03% | +3.3% |
| Q1 2020 | $10,317,000 | +114.1% | 464,514 | +95.7% | 0.03% | +150.0% |
| Q2 2019 | $4,818,000 | -40.2% | 237,317 | -48.3% | 0.01% | -40.0% |
| Q1 2019 | $8,062,000 | +79.7% | 458,869 | +31.2% | 0.02% | +66.7% |
| Q4 2018 | $4,487,000 | +9.9% | 349,751 | +39.6% | 0.01% | +20.0% |
| Q3 2018 | $4,081,000 | +408000.0% | 250,464 | +247884.2% | 0.01% | – |
| Q1 2018 | $1,000 | -66.7% | 101 | -77.7% | 0.00% | – |
| Q4 2017 | $3,000 | -40.0% | 452 | -61.4% | 0.00% | – |
| Q1 2017 | $5,000 | – | 1,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 569,889 | $46,987,000 | 60.92% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,379,064 | $278,604,000 | 36.08% |
| Darwin Global Management, Ltd. | 1,370,133 | $112,967,000 | 22.12% |
| Redmile Group, LLC | 12,957,222 | $1,068,323,000 | 15.05% |
| Copernicus Capital Management, LLC | 8,000 | $660,000 | 10.66% |
| Casdin Capital, LLC | 3,400,000 | $280,330,000 | 8.35% |
| Grosvenor Holdings, L.L.C. | 1,123,576 | $92,639,000 | 6.81% |
| DAFNA Capital Management LLC | 314,360 | $25,919,000 | 6.15% |
| Ally Bridge Group (NY) LLC | 270,000 | $22,262,000 | 4.27% |
| Ghost Tree Capital, LLC | 185,000 | $15,253,000 | 3.58% |